Literature DB >> 30035707

Chronic Illness with Complexity: Association With Self-Perceived Burden and Advance Care Planning.

Joanne Hash1, Susan Bodnar-Deren2, Elaine Leventhal3, Howard Leventhal4.   

Abstract

The present study examines how different chronic illnesses and mental illness comorbidity (chronic illness with complexity [CIC]) associate with components of advance care planning (ACP). We also explore the role self-perceived burden plays in the relationship between illness and ACP. Data were gathered from a cross-sectional survey of 305 elderly participants from the New Jersey End-of-Life study. Participants with diabetes and those with cardiovascular disease (CVD) are less likely, while participants with CIC are more likely, to plan for the end-of-life. Participants with diabetes are less likely to make formal plans, whereas those with CVD are less likely to hold informal discussions. CIC is associated with increased odds of having an advance directive, but no other form of ACP. Self-perceived burden did not appear to be the gateway by which illness groups differentially engaged in ACP. Future research should investigate what aspects of illnesses drive ACP.

Entities:  

Keywords:  advance care planning; burden; chronic illness; chronic illness with complexity; end-of-life

Mesh:

Year:  2016        PMID: 30035707     DOI: 10.1177/0030222816675250

Source DB:  PubMed          Journal:  Omega (Westport)        ISSN: 0030-2228


  2 in total

1.  The association between the number of chronic health conditions and advance care planning varies by race/ethnicity.

Authors:  Shinae Choi; Ian M McDonough; Minjung Kim; Giyeon Kim
Journal:  Aging Ment Health       Date:  2018-12-28       Impact factor: 3.658

2.  The Impact of Varying Levels of Advance Care Planning Engagement on Perceptions of the End-of-Life Experience Among Caregivers of Deceased Patients With Cancer.

Authors:  Kristin Levoy; Harleah Buck; Victoria Behar-Zusman
Journal:  Am J Hosp Palliat Care       Date:  2020-04-13       Impact factor: 2.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.